{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:00:37Z","timestamp":1778770837384,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Beijing Natural Science Foundation","award":["No. 7222124"],"award-info":[{"award-number":["No. 7222124"]}]},{"name":"National Research Institute for Family Planning","award":["2023GJZD01"],"award-info":[{"award-number":["2023GJZD01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02092-5","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:30:40Z","timestamp":1721791840000},"page":"839-854","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dimethyloxallyl Glycine Preconditioning Promotes the Anti-inflammatory and Anti-fibrotic Effects of Human Umbilical Cord Mesenchymal Stem Cells on Kidney Damage in Systemic Lupus Erythematosus Related to TGF-\u03b2\/Smad Signaling Pathway"],"prefix":"10.1007","volume":"48","author":[{"given":"Anfeng","family":"Ning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nansong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yichao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3305-9108","authenticated-orcid":false,"given":"Hongfei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"2092_CR1","doi-asserted-by":"publisher","unstructured":"Choi, M.Y., and K.H. Costenbader. 2022. Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development. Frontiers in Immunology 13: 890522. https:\/\/doi.org\/10.3389\/fimmu.2022.890522. (Published 2022 Jun 3).","DOI":"10.3389\/fimmu.2022.890522"},{"issue":"5","key":"2092_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani, S., A. Meara, and B.H. Rovin. 2017. Update on Lupus Nephritis. Clinical Journal of the American Society of Nephrology 12 (5): 825\u2013835. https:\/\/doi.org\/10.2215\/CJN.05780616.","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"3","key":"2092_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson, A. 2016. What is damaging the kidney in lupus nephritis? Nature Reviews Rheumatology 12 (3): 143\u2013153. https:\/\/doi.org\/10.1038\/nrrheum.2015.159.","journal-title":"Nature Reviews Rheumatology"},{"issue":"8","key":"2092_CR4","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/art.21955","volume":"54","author":"S Bernatsky","year":"2006","unstructured":"Bernatsky, S., J.F. Boivin, L. Joseph, et al. 2006. Mortality in systemic lupus erythematosus. Arthritis and Rheumatism 54 (8): 2550\u20132557. https:\/\/doi.org\/10.1002\/art.21955.","journal-title":"Arthritis and Rheumatism"},{"key":"2092_CR5","doi-asserted-by":"publisher","unstructured":"Weening, J.J., D'Agati, V.D., Schwartz, M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published correction appears in J Am Soc Nephrol. 2004 Mar;15(3):835\u20136]. J Am Soc Nephrol. 2004;15(2):241\u2013250. https:\/\/doi.org\/10.1097\/01.asn.0000108969.21691.5d","DOI":"10.1097\/01.asn.0000108969.21691.5d"},{"issue":"10","key":"2092_CR6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1056\/NEJM198603063141004","volume":"314","author":"HA 3rd Austin","year":"1986","unstructured":"3rd Austin, H.A., J.H. Klippel, J.E. Balow, et al. 1986. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. The New England Journal of Medicine 314 (10): 614\u2013619. https:\/\/doi.org\/10.1056\/NEJM198603063141004.","journal-title":"The New England Journal of Medicine"},{"key":"2092_CR7","doi-asserted-by":"publisher","unstructured":"Yang, Q., Y. Liu, G. Chen, W. Zhang, S. Tang, and T. Zhou. 2021. An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus. Stem Cells International 2021: 2168595. https:\/\/doi.org\/10.1155\/2021\/2168595. (Published 2021 Aug 13).","DOI":"10.1155\/2021\/2168595"},{"key":"2092_CR8","doi-asserted-by":"publisher","unstructured":"Kaul, A., C. Gordon, M.K. Crow, et al. 2016. Systemic lupus erythematosus. Nature Reviews Disease Primers 2: 16039. https:\/\/doi.org\/10.1038\/nrdp.2016.39. (Published 2016 Jun 16).","DOI":"10.1038\/nrdp.2016.39"},{"issue":"3","key":"2092_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","volume":"8","author":"A De Becker","year":"2016","unstructured":"De Becker, A., and I.V. Riet. 2016. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? World Journal of Stem Cells 8 (3): 73\u201387. https:\/\/doi.org\/10.4252\/wjsc.v8.i3.73.","journal-title":"World Journal of Stem Cells"},{"issue":"2","key":"2092_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.bmt.1702767","volume":"27","author":"PJ Shaughnessy","year":"2001","unstructured":"Shaughnessy, P.J., D.W. Ririe, D.L. Ornstein, et al. 2001. Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue. Bone Marrow Transplantation 27 (2): 221\u2013224. https:\/\/doi.org\/10.1038\/sj.bmt.1702767.","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"2092_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3727\/096368910X520056","volume":"20","author":"JW Chang","year":"2011","unstructured":"Chang, J.W., S.P. Hung, H.H. Wu, et al. 2011. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplantation 20 (2): 245\u2013257. https:\/\/doi.org\/10.3727\/096368910X520056.","journal-title":"Cell Transplantation"},{"issue":"3","key":"2092_CR12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semnephrol.2012.04.002","volume":"32","author":"HY Lan","year":"2012","unstructured":"Lan, H.Y., and A.C. Chung. 2012. TGF-\u03b2\/Smad signaling in kidney disease. Seminars in Nephrology 32 (3): 236\u2013243. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.04.002.","journal-title":"Seminars in Nephrology"},{"issue":"2","key":"2092_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T.A. 2008. Cellular and molecular mechanisms of fibrosis. The Journal of Pathology 214 (2): 199\u2013210. https:\/\/doi.org\/10.1002\/path.2277.","journal-title":"The Journal of Pathology"},{"issue":"3","key":"2092_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/kjm2.12505","volume":"38","author":"AH Rosendahl","year":"2022","unstructured":"Rosendahl, A.H., K. Sch\u00f6nborn, and T. Krieg. 2022. Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung Journal of Medical Sciences 38 (3): 187\u2013195. https:\/\/doi.org\/10.1002\/kjm2.12505.","journal-title":"Kaohsiung Journal of Medical Sciences"},{"issue":"7","key":"2092_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","volume":"7","author":"HY Lan","year":"2011","unstructured":"Lan, H.Y. 2011. Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation. International Journal of Biological Sciences 7 (7): 1056\u20131067. https:\/\/doi.org\/10.7150\/ijbs.7.1056.","journal-title":"International Journal of Biological Sciences"},{"issue":"4","key":"2092_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12015-019-09947-7","volume":"16","author":"B Zhou","year":"2020","unstructured":"Zhou, B., T. Ge, L. Zhou, et al. 2020. Dimethyloxalyl Glycine Regulates the HIF-1 Signaling Pathway in Mesenchymal Stem Cells. Stem Cell Reviews and Reports 16 (4): 702\u2013710. https:\/\/doi.org\/10.1007\/s12015-019-09947-7.","journal-title":"Stem Cell Reviews and Reports"},{"key":"2092_CR17","doi-asserted-by":"publisher","first-page":"107901","DOI":"10.1016\/j.intimp.2021.107901","volume":"99","author":"MH Chen","year":"2021","unstructured":"Chen, M.H., Y.H. Wang, B.J. Sun, et al. 2021. HIF-1\u03b1 activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization. International Immunopharmacology 99: 107901. https:\/\/doi.org\/10.1016\/j.intimp.2021.107901.","journal-title":"International Immunopharmacology"},{"issue":"6","key":"2092_CR18","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/01.moh.0000177827.78280.79","volume":"12","author":"R Sackstein","year":"2005","unstructured":"Sackstein, R. 2005. The lymphocyte homing receptors: Gatekeepers of the multistep paradigm. Current Opinion in Hematology 12 (6): 444\u2013450. https:\/\/doi.org\/10.1097\/01.moh.0000177827.78280.79.","journal-title":"Current Opinion in Hematology"},{"key":"2092_CR19","doi-asserted-by":"publisher","unstructured":"Zhang, L., C. Ye, P. Li, et al. 2022. ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C\/VEGFR-3-dependent mechanism and inhibiting the NF-\u03baB pathway by the secretome. Stem Cell Research & Therapy 13 (1): 448. https:\/\/doi.org\/10.1186\/s13287-022-03132-3. (Published 2022 Sep 5).","DOI":"10.1186\/s13287-022-03132-3"},{"issue":"8","key":"2092_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jcyt.2023.04.005","volume":"25","author":"S Viswanathan","year":"2023","unstructured":"Viswanathan, S., K.L. Blanc, R. Ciccocioppo, et al. 2023. An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization\/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes. Cytotherapy 25 (8): 803\u2013807. https:\/\/doi.org\/10.1016\/j.jcyt.2023.04.005.","journal-title":"Cytotherapy"},{"issue":"4","key":"2092_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal, S., and M.F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (4): 1815\u20131822. https:\/\/doi.org\/10.1182\/blood-2004-04-1559.","journal-title":"Blood"},{"issue":"1","key":"2092_CR22","doi-asserted-by":"publisher","first-page":"e000611","DOI":"10.1136\/lupus-2021-000611","volume":"9","author":"XC Chen","year":"2022","unstructured":"Chen, X.C., D. Wu, H.L. Wu, et al. 2022. Metformin improves renal injury of MRL\/lpr lupus-prone mice via the AMPK\/STAT3 pathway. Lupus Sci Med. 9 (1): e000611. https:\/\/doi.org\/10.1136\/lupus-2021-000611.","journal-title":"Lupus Sci Med."},{"key":"2092_CR23","doi-asserted-by":"publisher","unstructured":"Li, D., G. Shi, J. Wang, et al. 2019. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2\/HO-1 in myeloid-derived suppressor cells. Arthritis Research & Therapy 21 (1): 105. https:\/\/doi.org\/10.1186\/s13075-019-1876-0. (Published 2019 Apr 25).","DOI":"10.1186\/s13075-019-1876-0"},{"issue":"7","key":"2092_CR24","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s10238-023-01093-2","volume":"23","author":"J Tian","year":"2023","unstructured":"Tian, J., T. Huang, J. Chen, et al. 2023. SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS\/TRPM2\/Ca2+ channel. Clinical and Experimental Medicine 23 (7): 3465\u20133478. https:\/\/doi.org\/10.1007\/s10238-023-01093-2.","journal-title":"Clinical and Experimental Medicine"},{"issue":"4","key":"2092_CR25","doi-asserted-by":"publisher","first-page":"e811","DOI":"10.1002\/iid3.811","volume":"11","author":"L Liu","year":"2023","unstructured":"Liu, L., Y. Zhang, and L. Zhong. 2023. LncRNA TUG1 relieves renal mesangial cell injury by modulating the miR-153-3p\/Bcl-2 axis in lupus nephritis. Immunity, Inflammation and Disease 11 (4): e811. https:\/\/doi.org\/10.1002\/iid3.811.","journal-title":"Immunity, Inflammation and Disease"},{"key":"2092_CR26","doi-asserted-by":"publisher","unstructured":"Xu, J.W., M.Y. Wang, Y. Mao, et al. 2024. Inhibition of STAT3 alleviates LPS-induced apoptosis and inflammation in renal tubular epithelial cells by transcriptionally down-regulating TASL. European Journal of Medical Research 29 (1): 34. https:\/\/doi.org\/10.1186\/s40001-023-01610-9. (Published 2024 Jan 6).","DOI":"10.1186\/s40001-023-01610-9"},{"issue":"5","key":"2092_CR27","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1007\/s10753-021-01487-y","volume":"44","author":"ZQ Xu","year":"2021","unstructured":"Xu, Z.Q., Y. Ding, X.Y. Huang, W. Xiang, and X.J. He. 2021. CircELK4 Contributes to Lupus Nephritis by Acting as a miR-27b-3p Sponge to Regulate STING\/IRF3\/IFN-I Signaling. Inflammation 44 (5): 2106\u20132119. https:\/\/doi.org\/10.1007\/s10753-021-01487-y.","journal-title":"Inflammation"},{"issue":"4","key":"2092_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/sj.bmt.1702152","volume":"25","author":"E Jantunen","year":"2000","unstructured":"Jantunen, E., and R. Myllykangas-Luosuj\u00e4rvi. 2000. Stem cell transplantation for treatment of severe autoimmune diseases: Current status and future perspectives. Bone Marrow Transplantation 25 (4): 351\u2013356. https:\/\/doi.org\/10.1038\/sj.bmt.1702152.","journal-title":"Bone Marrow Transplantation"},{"key":"2092_CR29","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.jaut.2022.102871","volume":"132","author":"C Yu","year":"2022","unstructured":"Yu, C., P. Li, X. Dang, X. Zhang, Y. Mao, and X. Chen. 2022. Lupus nephritis: New progress in diagnosis and treatment. Journal of Autoimmunity 132: 102871. https:\/\/doi.org\/10.1016\/j.jaut.2022.102871.","journal-title":"Journal of Autoimmunity"},{"issue":"Suppl5","key":"2092_CR30","doi-asserted-by":"publisher","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","volume":"59","author":"M Gasparotto","year":"2020","unstructured":"Gasparotto, M., M. Gatto, V. Binda, A. Doria, and G. Moroni. 2020. Lupus nephritis: Clinical presentations and outcomes in the 21st century. Rheumatology (Oxford) 59 (Suppl5): v39\u2013v51. https:\/\/doi.org\/10.1093\/rheumatology\/keaa381.","journal-title":"Rheumatology (Oxford)"},{"key":"2092_CR31","doi-asserted-by":"publisher","unstructured":"Yu, H., Y. Nagafuchi, and K. Fujio. 2021. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules. 11 (7): 928. https:\/\/doi.org\/10.3390\/biom11070928. (Published 2021 Jun 22).","DOI":"10.3390\/biom11070928"},{"issue":"9","key":"2092_CR32","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","volume":"77","author":"G Moroni","year":"2018","unstructured":"Moroni, G., P.G. Vercelloni, S. Quaglini, et al. 2018. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Annals of the Rheumatic Diseases 77 (9): 1318\u20131325. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212732.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"2092_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema, I.M., S. Wilhelmus, C.E. Alpers, et al. 2018. Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: Clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney International 93 (4): 789\u2013796. https:\/\/doi.org\/10.1016\/j.kint.2017.11.023.","journal-title":"Kidney International"},{"key":"2092_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clim.2016.09.002","volume":"185","author":"S Yung","year":"2017","unstructured":"Yung, S., and T.M. Chan. 2017. Anti-dsDNA antibodies and resident renal cells - Their putative roles in pathogenesis of renal lesions in lupus nephritis. Clinical Immunology 185: 40\u201350. https:\/\/doi.org\/10.1016\/j.clim.2016.09.002.","journal-title":"Clinical Immunology"},{"key":"2092_CR35","doi-asserted-by":"publisher","unstructured":"Wright, R.D., P. Dimou, S.J. Northey, and M.W. Beresford. 2019. Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus. Journal of Inflammation (London) 16: 22. https:\/\/doi.org\/10.1186\/s12950-019-0227-x. (Published 2019 Nov 14).","DOI":"10.1186\/s12950-019-0227-x"},{"key":"2092_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","volume":"292","author":"HH Hu","year":"2018","unstructured":"Hu, H.H., D.Q. Chen, Y.N. Wang, et al. 2018. New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis. Chemico-Biological Interactions 292: 76\u201383. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.008.","journal-title":"Chemico-Biological Interactions"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02092-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02092-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T09:05:16Z","timestamp":1746435916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02092-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2092"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02092-5","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"assertion":[{"value":"11 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Animal Care and Laboratory Animal Welfare Ethics Committee of the National Research Institute for Family Planning approved all animal experiments and procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}